TABLE 1.
Virus | Groupa | Case description
|
Passage no.
|
Infectivity titer (log10/ml)b
|
MID50c | LD50d | |||
---|---|---|---|---|---|---|---|---|---|
Age (yr)/gender | Outcome | MDCK | Eggs | TCID50 | EID50 | ||||
HK/483 | B | 13/female | Fatal | 1 | 3 | 8.5 | 9.0 | 2.2 | 2.4 |
HK/485 | B | 24/female | Severe/recovered | 2 | 2 | 8.5 | 8.7 | 1.1 | 2.9 |
HK/156 | A | 3/male | Fatal | 0 | 3 | 7.7 | 10.0 | 3.2 | 5.9 |
HD/486 | A | 5/female | Mild/recovered | 2 | 4 | 8.7 | 9.0 | 1.2 | >7 |
X-31 (H3N2) | NAe | NA | 0 | >10 | 7.3 | 8.5 | 0.7 | >5.2 |
Antigenic/genetic group of H5N1 viruses isolated from humans (3).
Calculated by the method of Reed and Muench (24) from the results of serial titrations of viruses in MDCK cells and embryonated eggs.
Expressed as the EID50 required to give 1 MID50.
Expressed as the EID50 required to give 1 LD50.
NA, not applicable.